Patheon sells global secondary clinical packaging services business to Bellwyck

By Admin
Patheon Inc said it has sold its global secondary clinical packaging and clinical distribution services business to Bellwyck Packaging Solutions. The c...

Patheon Inc said it has sold its global secondary clinical packaging and clinical distribution services business to Bellwyck Packaging Solutions.

The company Bellwyck Solutions is a private company engaged in providing clinical trial and contract services for secondary packaging.

Patheon’s Chief Executive Officer, James C Mullen said, “We are very happy to have reached an agreement with Bellwyck for this business.”

Mr. Mullen also said, “While we don’t expect the terms of the transaction to have a material impact on our on-going results, this transaction is part of our continued focus on our core competencies of solid-dose and parenteral development and manufacturing. One of Bellwyck’s core competencies is clinical packaging. We are confident that both the customers and our employees, about 20 of whom have joined Bellwyck, are in good hands.”

Bellwyk’s Co-CEO Jeff Sziklai said, “We look forward to an ongoing partnership with Patheon as we work together to ensure that Bellwyck continues to provide superior clinical packaging and distribution services to Patheon’s current and future customers. We anticipate a seamless transition for customers and employers.”

Patheon Inc is a leading provider of contract development and manufacturing services to the global pharma industry. It is engaged in providing high quality products and services to 300 of the world’s leading pharmaceutical and biotechnology companies.

Share
Share

Featured Articles

Snowflake: Transforming patient healthcare with Gen AI

Jesse Cugliotta, Healthcare & Life Science at Snowflake, discusses revolutionising healthcare efficiency and improving patient care with Gen AI

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

Digital Healthcare

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML